Quick Answer
LakeShore Biopharma Co., Ltd. reported Research And Development Expense of $20.39 million for the year ending 2025.
- LakeShore Biopharma Co., Ltd. showed a decrease of -93.3% in Research And Development Expense from 2024 to 2025.
- This data is from LakeShore Biopharma Co., Ltd.'s annual report (Form 10-K), filed with the SEC on July 31, 2025.
- XBRL data for this metric is available from 2021 to 2025 (5 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Over the full 5 years of available data (2021 to 2025), LakeShore Biopharma Co., Ltd.'s Research And Development Expense has declined by 78.4%.
- Historical annual values: Fiscal year 2025: $20.39 million | Fiscal year 2024: $302.80 million | Fiscal year 2023: $318.70 million | Fiscal year 2022: $211.22 million | Fiscal year 2021: $94.39 million.
- Data sourced from SEC EDGAR public filings as of June 21, 2026.
Last verified: